article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

The FDA describes these products under enforcement discretion if they are intended to inform clinical management for nonserious situations or conditions, help patients self-manage their disease or conditions without providing specific treatment, or automate simple tasks for health care providers. Published 28 January 2016.

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

The FDA describes these products under enforcement discretion if they are intended to inform clinical management for nonserious situations or conditions, help patients self-manage their disease or conditions without providing specific treatment, or automate simple tasks for health care providers. Published 28 January 2016.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Incredible Shrinking Exemption: FDA Final CDS Guidance Would Significantly Narrow the Scope of Exempt Clinical Decision Support Software Under the Cures Act

The FDA Law Blog

Javitt — On September 28, 2022, the FDA issued the long anticipated final Clinical Decision Support Software Guidance (CDS Guidance), which replaces the revised draft guidance document from 2019.

FDA 52
article thumbnail

Highlights from ESCMID Global 2024: AI, climate change and AMR

Hospital Pharmacy Europe

Bhat, head of department – central laboratory and consultant microbiologist and infection control officer at St Martha’s Hospital, Bengaluru, India, showcased her work with ChatGPT in the clinical microbiology laboratory. In microbiologically documented HAIs, 32% of microorganisms were resistant to antimicrobials.